jump to content jump to footer

University Hospital Cologne: Study provides guidance values of iodine concentration for body CT examinations

Using data from a large cohort of individuals without radiological tumor burden, researchers from University Hospital Cologne have conducted a study [1] aiming at establishing guidance values for absolute iodine concentrations and perfusion ratios of various abdominal organs and lymph nodes, as well as other anatomical landmarks.
 
Iodinated contrast media are nearly always administered in oncologic computer tomography (CT) imaging, and dual-energy CT (DECT) allows for accurate and reliable quantification of iodine, providing information regarding its distribution. “To pave the road towards clinical application of iodine quantification […] it is pivotal to understand normal distribution and cohort-specific variance of these [iodine] values,” explains PD Dr. Große Hokamp. “However, data on physiological iodine distribution in subjects without tumor burden is sparse.”
 
571 portal venous phase dual-layer spectral detector CT studies of the chest and abdomen from patients with no tumor burden confirmed by follow-up imaging after at least three months were assessed. The researchers used mint Lesion™ to place a total of 37 ROI per examination in parenchymatous organs (n = 25), lymph nodes (n= 6), and vessels (n = 3) on conventional images and to copy them to identical positions in iodine maps.
 
For each ROI, iodine concentration (IC) and its standard deviation were exported. The distribution parameter was calculated to assess the spread of IC and iodine perfusion ratio.
 
Absolute iodine concentration significantly differed between body mass index (BMI), genders, and age groups in parenchymatous organs, lymph nodes, and vessels (range 0.0 ± 0.0 mg/ml – 6.6 ± 1.3 mg/ml). For instance, higher results were observed for female patients in all ROI (all p ≦0.004). “Hence, care should be taken in providing cutoff values of iodine concentration to differentiate between healthy and malignant abdominal lesions,” the researchers emphasized. “Particularly in studies with a small patient sample, any bias with regard to age and/or sex should be considered and accounted, e. g., in studies with cohorts of higher age, an adaptation to decreased perfusion values should be conducted.”
 
Widespread differences in iodine perfusion ratios between genders and age groups were recorded in almost all abdominal organs when applying a fixed volume of contrast media. Therefore, the researchers suggest “normalizing absolute iodine concentrations to adjust for the ratio of body weight and applied amount of contrast media.”
 
This study provides guidance values of IC valid for examinations based on results obtained from a dual-layer SDCT only. “Yet, as different studies showed that iodine quantification can be accurately performed on all different DECT scanners, examinations with a comparable examination protocol can be expected to provide similar results,” the authors pointed out.
 
Nevertheless, to make quantitative imaging parameters from DECT applicable in clinical settings, international agreement and guidance should be defined by professional societies in cooperation with hardware and software manufacturers – similar to the efforts that have been successfully made by the Quantitative Imaging Biomarkers Alliance and the European Imaging Biomarkers Alliance for different other imaging techniques.
 
[1] Zopfs, D., Graffe, J., Reimer, R.P., …, Große Hokamp N. Quantitative distribution of iodinated contrast media in body computed tomography: data from a large reference cohort. Eur Radiol (2020), https://doi.org/10.1007/s00330-020-07298-3

Mint Medical and Coreline teams coming together to announce partnership
Mint Medical and Coreline Soft integrate AVIEW into mint Lesion to support AI-enabled workflows for structured reporting, Lung-RADS assessment, and longitudinal nodule management in lung cancer screening.
Coreline Soft and Mint Medical Announce Partnership to Advance AI-Enabled Lung Cancer Screening
Coreline Soft and Mint Medical today announced a partnership to advance AI-enabled lung cancer screening, following more than six months of technical…
Read more
Integrated prostate cancer workflow connecting radiology, urology, and pathology through structured reporting, MRI-guided biopsy, longitudinal follow-up, and AI-supported analysis.
mint Lesion supports an end-to-end prostate cancer workflow by connecting radiology, urology, and pathology within a unified digital environment. The platform enables structured mpMRI reporting, MRI/ultrasound fusion biopsy workflows, FHIR-based interoperability, active surveillance, and AI-supported quantification of metastatic disease.
Be Central to the Insight: A Structured, Data-Driven Approach to the End-to-End Prostate Pathway
Digital Integration for Multidisciplinary Teams  In the complex journey of prostate cancer diagnostics, the data contributed by every department is…
Read more
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026
Presentation of a research poster by Memorial Sloan Kettering Cancer Center on the use of mint Lesion for structured tumor response assessments and clinical research workflows.
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Read more
scroll-top